170
Participants
Start Date
September 30, 2007
Primary Completion Date
February 28, 2019
MyoCell
Patient will receive injections of cultured, expanded skeletal myoblasts into the myocardium at a dose of 400 million cells.
MyoCell
Patient will receive injections of cultured, expanded skeletal myoblasts into the myocardium at a dose of 800 million cells.
Hypothermosol
After the cell culture period of time has passed, patient's myocardium will be injected with the transport media alone. Patient will not receive any cultured myoblasts during these injections.
Columbia University Medical Center, New York
University of Pittsburgh Medical Center, Pittsburgh
Duke University Medical Center, Durham
Emory/Crawford Long, Atlanta
St. Joseph's Research Institute/ACRI, Atlanta
University of Florida Shands, Jacksonville
University of Florida, Gainesville
Florida Hospital Center Cardiovascular Center, Orlando
University of Miami Miller School of Medicine, Miami
Jim Moran Heart and Vascular Research Institute, Fort Lauderdale
Cardiology, P.C., Birmingham
University of Alabama, Birmingham
Stern Cardiology, Germantown
The Ohio State University Medical Center, Columbus
University Hospital, Case Western Reserve University, Cleveland
Cleveland Clinic, Cleveland
The Lindner Center, Cincinnati
University of Iowa Hospitals and Clinics, Iowa City
St. Luke's Medical Center, Milwaukee
Minneapolis Heart Institute, Minneapolis
RUSH University Medical Center, Chicago
Ochsner Medical Center, New Orleans
University of Oklahoma, Oklahoma City
Texas Heart Institute, Houston
Arizona Heart Institute, Phoenix
Mayo Clinic Hospital, Phoenix
Mercy Gilbert Medical Center, Gilbert
Scripps Green Hospital, La Jolla
UCSD Medical Center, La Jolla
Swedish Medical Center, Seattle
Our Lady of Lourdes Medical Center, Camden
Gagnon Heart Hospital, Morristown
Newark Beth Israel Medical Center, Newark
Lead Sponsor
Bioheart, Inc.
INDUSTRY